Developing therapies for the treatment of bone defects and myocardial regeneration, based on somatic stem cells, isolated from cord blood. Investor data and overview of company in Langenfeld, Germany.

Offers lines of normal human embryonic stem cells, and genetically abnormal variants to scientists and researchers. with sub-licensing to commercial and scientific institutions from London, UK.

Offers stem cell researchers a method of opening the zona for insertion or withdrawal of genetic material. From Hamilton Thorne Biosciences Inc., Beverly, Massachusetts.

A Parent's Guide to Cord Blood Banks.... with emphasis on how to evaluate private bank services. Our mission is to provide an impartial review of cord blood storage options for parents who are contemplating this form of medical "insurance". We review the medical motivations for banking umbilical cord blood and the difference between donating to a public bank versus private banking. We provide master lists of both public banks and private banks.

Legislative, administrative and judicial actions concerning stem cell research.

Company conducts research using autologous human cells in a serum free medium to treat incurable diseases. The results propose possible new treatments for regeneration of diseased tissues. Based in Geneva, Switzerland.

Specializing initially in hematopoietic stem cells and developing expansion from umbilical cord blood using its proprietary bioreactor and 3-D technology platform. Includes investor data and overview of company in Haifa, Israel.

Developing therapy by the transplantation of the patient's own cell-line after isolation and processing in vitro, to replace, repair or enhance the function of damaged tissues. Clinical trials based in Bangkok, Thailand and Kiryat Weizmann, Israel.

Publishes peer-reviewed research papers on opportunities for mammalian cells in medicine and agriculture, along with the culture and differentiation from all stages of development from embryo to adult. Includes current issue, abstracts and search with full text as online purchase or subscription from Mary Ann Liebert, Inc, New York.

A conservative Christian's argument against stem cell research on human embryos.